Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

PBPHvsHRTSETF Comparison

ETF 1
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
+0.15%
VS
ETF 2
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
-0.8%

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) is part of the Tomorrow's Treatments segment. PBPH's top 3 sector exposures are Health Care and Consumer Staples. In contrast, HRTS's top sector exposures are Health Care  PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.99% for HRTS. PBPH is up 1.62% year-to-date (YTD) with +$830M in YTD flows. HRTS performs worse with -2.9% YTD performance, and -$1M in YTD flows. Run a side-by-side ETF comparison of PBPH and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBPH vs HRTS performance and flow charts

Performance

-1.00.01.02.03.04.05.0%May 18May 25Jun 1Jun 8Jun 15

Cumulative Flows

05,000,00010,000,00015,000,000May 18May 25Jun 1Jun 8Jun 15

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/16/2026
1M3MYTD1Y3Y5Y
Perf.
PBPH
HRTS
+3.39%+2.92%
-0.01%+0.65%
+1.62%-2.90%
n/a+20.99%
n/an/a
n/an/a
Flows
PBPH
HRTS
+$15M+$344K
+$95M-$339K
+$830M-$1M
--$8M
--
--
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBPH
HRTS
+17.23%+17.22%
n/a+15.70%
n/an/a
n/an/a
Max drawdown
PBPH
HRTS
-5.84%-5.26%
n/a-10.68%
n/an/a
n/an/a
Max drawdown duration
PBPH
HRTS
56d58d
n/a160d
n/an/a
n/an/a
Trading data

Create an account to view trading data

Join for free
PBPH
HRTS
Last sale
6/17/2026 at 1:30 PM
$25.60
$34.13
Previous close
06/16/2026
$25.67
$34.30
Consolidated volume
06/16/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PBPH
HRTS
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/17/2026 at 1:30 PM
Live
Closed
PBPH
HRTS
Last price
$25.60
$34.13
1D performance
-0.27%
-0.49%
AuM$802.32 M$52.15 M
E/R0.13%0.99%
Characteristics
PBPH
HRTS
Management strategyPassiveActive
ProviderTidalTema
BenchmarkBITA Global Pharma and Biotech Select Index-
N° of holdings4938
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 24, 2025November 21, 2023
ESGNoNo
Advertisement
Exposure

Countries

PBPH
USA
62.04%
Other
37.96%
HRTS
USA
81.88%
Other
18.12%

Sectors

PBPH
Health Care
88.29%
Other
11.71%
HRTS
Health Care
86.6%
Other
13.4%
Advertisement

Diversification

PBPH

Total weight of top 15 holdings out of 15

67.47%
HRTS

Total weight of top 15 holdings out of 15

61.36%

Top 15 holdings

Data as of April 30, 2026
PBPH
LILLY
12.31%
JOHNSON&JOHNSON
9.12%
ABBVIE
5.86%
NOVARTIS
4.60%
MERCK & CO INC
4.57%
AMGEN-T
4.35%
GILEAD SCIENCES
4.23%
PFIZER
4.06%
NOVO-NORDISK
3.52%
BRISTOL-MYERS SQUIBB
3.13%
VERTEX PHARMACEUTICALS
2.88%
GSK PLC
2.73%
SANOFI SA
2.69%
REGENERON PHARMACEUTICALS
2.03%
CSL
1.39%
HRTS
LILLY
9.40%
UNITEDHEALTH GRP
5.08%
US7711951043
4.92%
ASTRAZENECA
4.23%
JOHNSON&JOHNSON
4.23%
MERCK & CO INC
4.12%
DK0062498333
3.96%
THERMO FISHER SCIENTIFIC
3.92%
GILEAD SCIENCES
3.39%
NOVARTIS
3.38%
VERTEX PHARMACEUTICALS
3.14%
BRIDGEBIO PHARMA
3.03%
ABBOTT LABS
2.93%
REVOLUTION MEDICINES INC
2.89%
ABBVIE
2.74%
Frequently asked questions about PBPH and HRTS

How have the PBPH and HRTS ETFs performed in 2026?

As of June 16, 2026, PBPH is up 1.62% year-to-date (YTD), while HRTS has lost -2.9%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or HRTS?

Year-to-date, the PBPH ETF saw +$830M in flows, compared to -$1M for HRTS.

Which ETF is bigger: PBPH or HRTS?

As of June 16, 2026, PBPH holds $802.32 M in assets under management (AUM), while HRTS manages $52.15 M.

What sectors do the PBPH and HRTS ETFs invest in?

PBPH leans toward sectors like Health Care. Meanwhile, HRTS focuses on Health Care.

What are the top holdings of the PBPH ETF and HRTS ETF?

PBPH top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. HRTS holds in its top three: LILLY, UNITEDHEALTH GRP and US7711951043.

Which ETF is more diversified: PBPH or HRTS?

PBPH holds 49 securities with 67.47% of its assets in the top 15. HRTS has 43 securities and a top 15 weight of 61.36%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026